Discover

ICCC
ImmuCell Corporation
11.00
1 x 10.85
1 x 11.10
bid
ask
+
0.03
0.27%
01:29 PM
timesize
Ytd78.86%
1y65.17%
10.62
day range
11.06
4.52
52 week range
12.10
Open11.06Prev Close10.97Low10.62High11.06Mkt Cap99.51M
Vol4.56KAvg Vol29.47KEPS-0.06P/E-183.33Forward P/E-42.82
Beta0.54Short Ratio0.23Inst. Own14.51%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg10.44200-d Avg7.631yr Est14.00

ICCC News

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
globenewswire.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

ImmuCell: First Defense With Better Execution
seekingalpha.com
ImmuCell: First Defense With Better Execution

ImmuCell's main value driver is First Defense. In my view, this is their core franchise and has real

ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
zacks.com
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand

ICCC reports an 11.5% rise in preliminary Q2 sales, driven by robust U.S. demand and improved produc

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
globenewswire.com
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six

PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

ICCC's Valuation Remains Premium: Is it Worth Overpaying for?
zacks.com
ICCC's Valuation Remains Premium: Is it Worth Overpaying for?

ImmuCell's premium valuation is backed by rising output, First Defense share gains and a sizable unt

ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
zacks.com
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand

ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health produ

ImmuCell Q1 Earnings Call Highlights
marketbeat.com
ImmuCell Q1 Earnings Call Highlights

ImmuCell NASDAQ: ICCC reported a record first quarter of 2026, with management saying the company's

ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript
seekingalpha.com
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript

ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
globenewswire.com
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
globenewswire.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or

The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell
zacks.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell

Goldman Sachs, NextEra Energy and Shopify lead top stock reports, highlighting strong gains, expandi

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
globenewswire.com
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthon

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
globenewswire.com
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited

PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average   – Here’s Why
defenseworld.net
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why

ImmuCell Corporation (NASDAQ: ICCC - Get Free Report) crossed above its 200-day moving average durin

ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
globenewswire.com
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell Q4 Earnings Call Highlights
defenseworld.net
ImmuCell Q4 Earnings Call Highlights

ImmuCell (NASDAQ: ICCC) executives used the company's fourth-quarter and full-year 2025 earnings cal

ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve
zacks.com
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve

ICCC's 2025 sales rise 4.3% y/y, with the gross margin expanding sharply, helping narrow its annual

ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
seekingalpha.com
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript

ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
globenewswire.com
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

Earnings Scheduled For March 4, 2026
benzinga.com
Earnings Scheduled For March 4, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
globenewswire.com
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For November 13, 2025
benzinga.com
Earnings Scheduled For November 13, 2025

benzinga.com
Earnings Scheduled For August 14, 2025

benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For May 14, 2025

benzinga.com
Earnings Scheduled For February 25, 2025

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Earnings Scheduled For November 13, 2024

benzinga.com
Earnings Scheduled For February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

benzinga.com
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

benzinga.com
Earnings Scheduled For August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 199 companies reached new 52-week lows.

benzinga.com
Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  Thursday's session saw 337 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For February 21, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f

benzinga.com
Earnings Scheduled For November 21, 2022

Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earni

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 400 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 12, 2021

  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

benzinga.com
Earnings Scheduled For May 13, 2021

  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday